Skip to main content
. 2012 Jul;1(1):23–34. doi: 10.3978/j.issn.2224-4336.2012.03.03

Table 2. pH probe results.

Placebo + Placebo (n=4)
Omeprazole + Bethanacol (n=6)
Omeprazole + Placebo (n=3)
Bethanacol + Placebo (n=5/3)
Pre Post Pre Post Pre Post Pre Post
pH Probe Score 39.5 (33.0-62.4) 92.6 (67.0-114.6) 60.0 (21.2-141.4) 17.8 (16.1-24.9) 46.7 (25.6-154.6) 13.2 (10.4-14.7) 79.1 (29.4-136.7) 34.6 (20.7-45.3)
Number of Episodes (pH<4) 87.5 (61.5-167.5) 173.0 (112.0-285.5) 141.5 (126-359) 78.0* (41-121) 98.0 (76.3-167.8) 40.0 (34.8-44.5) 102.0 (11.5-421.5) 79.0 (72.3-105.3)
% Time pH<4 8.1 (5.3-11.7) 18.1 (12.2-23.4) 11.3 (3.8-24.9) 2.8* (1.1-3.3) 3.6 (3.0-24.8) 1.3 (0.6-1.7) 11.2 (3.5-21.8) 3.4 (2.4-7)

*P=0.028 after Wilcoxin signed rank analysis of pre vs. post values.